#genetic methylation test cost in india | Explore Tumblr posts and blogs

newinnovationalmarketresearch · 4 years ago

Text

Epigenetics Market Research (2020-2025) Report by Driving Factors, Industry Growth, Key Vendors

Epigenetics Market Research Report (2020-2025) Provides In-Depth Analysis by Scope, Growth Rate, Driving Factors, Competitive Situation, Top Manufacturers and Upcoming Trends. Epigenetics Market report split global into several key Regions which mainly includes Market Overview, Table of Content, List of Figures and Applications. Epigenetics Market Growing at Higher CAGR Rate of XX% between (2020-2025).

Summery:-

The global Epigenetics Market is expected to value at USD 22.05 billion in 2025, exhibiting a CAGR of 19.7% during the forecast period of 2018 to 2025. Rapid surge in the product demand is credited to the ever-growing geriatric population and prevalence of chronic diseases. Globally, the epigenetics market is predicted to generate massive revenue over the forecast period, providing numerous opportunities for industry participants to invest in research and development of epigenetics services.

Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/epigenetics-market-size/request-sample

The key driving factors responsible for the growth of Epigenetics market :

The identification of severity among patients suffering from chronic diseases and successful execution of disease management are other major factors driving the growth of the genetic testing services domain. High-end demand for latest technologies in healthcare sector and collective research and development (R&D) activities in the area of genetics is anticipated to foster industry growth as well.

Several diagnostic and testing organization have launched innovative products including antibodies specific for identification of modifications and advanced kits for simple and efficient detection of biomarkers. Furthermore, development of therapeutic drugs by healthcare providers is anticipated to work in favor of the epigenetics market. Introduction of pipeline drugs and rising approval rate from local and international authorities is estimated to augment epigenetics industry growth over the coming years.

Rising approval rate for therapeutic drugs and epigenetics services is the key industry trend over the past few years. For example, Eli Lilly and Co., global pharmaceutical company, has unveiled its product line of advanced therapeutic drugs Ramucirumab (Cyramza), which is recently approved by FDA. Shifting focus towards the epigenetics services by pharmaceutical companies for detecting of methylation markers during cancer treatment is expected to favor epigenetics industry growth. Epigenomics AG has developed Epi proLung BL Reflex Assay that allows simple diagnosis for lung cancer.

Epigenetics services allows understanding of phenotype changes, which involves alterations in the DNA sequence. Epigenetics testing is performed on various blood sample taken during different time period in person’s life. The fast paced technological advancement in epigenetics testing and sequencing methodologies, has led to the vast expansion of epigenetics testing in preventive healthcare management.

View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/epigenetics-market-size

Table of Contents:-

• Epigenetics Market Overview

• Epigenetics Market Competition by Manufacturers

• Epigenetics Market Production, Revenue (Value) by Region (2014-2025)

• Epigenetics Market Supply (Production), Consumption, Export, Import by Regions (2014-2025)

• Epigenetics Market Production, Revenue (Value), Price Trend by Type

• Epigenetics Market Analysis by Application

• Epigenetics Market Manufacturers Profiles/Analysis

• Epigenetics Market Manufacturing Cost Analysis

• Epigenetics Market Industrial Chain, Sourcing Strategy and Downstream Buyers

• Epigenetics Market Marketing Strategy Analysis, Distributors/Traders

• Epigenetics Market Effect Factors Analysis

• Epigenetics Market Research Findings and Conclusion

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: [email protected]

Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

tel: 91-20-65300184

Email: [email protected]

0 notes

rishabh3210blog · 5 years ago

Text

Global Next Generation Sequencing Market Size, Share and Forecast to 2025

The global next generation sequencing market is projected to exhibit a significant growth, at a CAGR of around 16.4%, during the forecast period. The increasing adoption of personalized medicines for the treatment of cancer is augmenting the growth of the next generation sequencing technology market. Personalized medicine has the potential to modify therapy with the best response and highest safety margin to ensure better patient care. By enabling these medicines, each patient can receive earlier diagnoses, risk assessments, and optimal treatments. The personalized medicine holds promise for improving healthcare while lowering costs which is expected to be a positive indicator for the growth of the global next generation sequencing market.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/next-generation-sequencing-market

The personalized medicine is defined as a point of care in the treatment that is customized as per an individual patient. There have been several types of research going on presently to develop personalized medicine based on the patients. Several factors should be considered before providing personalized medicine to a patient. Primarily, the doctors must detect the type of diseases, such as cancer, or the symptoms of it that can be developed in a patient. Detection of cancer is important for the surgeon or the doctor to find the best-suited therapy that can treat the person.

A Full Report of Global Next Generation Sequencing Market is Available at: https://www.omrglobal.com/industry-reports/next-generation-sequencing-market

For developing of personalized medicine, several genetic tests need to be taken in account as these tests will eventually reveal the various conditions of the patients such as detection of the individual developing a specific type of cancer. The personalized medicine provides an approach to treat the patient based on the age, sex, type of cancer, the reaction towards a drug and other factors. As per the Personalized Medicine Coalition (PMC) 2017 report, around 42% of all compounds and around 73% of oncology compounds in the pipeline have the potential to be included in personalized medicines.

The biopharmaceutical companies closely doubled their R&D investment in personalized medicine over the past five years and suppose to increase their investment in the near future. The US FDA has received a significant number of personalized medicines for its approval in the past years. As per the US FDA data, the organization has approved around 21% of personalized medicines in 2014, which rammed up to 34% in 2017.

Global Next Generation Sequencing Market-Segmentation

By Product Type

Reagents and Kits

Instruments

Services

By Technology

Pyrosequencing

Sequencing by Synthesis (SBS)

Sequencing by Ligation (SBL)

Whole Genome Sequencing

RNA Sequencing

Targeted Resequencing

Others (Methyl Sequencing)

By Application

Drug Discovery

Genomic Research

Disease Diagnostics

Personalized Medicine

Others (Agricultural and Animal Research)

By End-User

Academic and Clinical Research Centers

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CRO)

Hospitals and Clinics

Global Next Generation Sequencing Market– Segment by Region

North America

United States

Canada

Europe

Germany

France

Spain

Italy

Rest of Europe

Asia-Pacific

China

Japan

India

Rest of Asia-Pacific

Rest of the World

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/next-generation-sequencing-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: [email protected] Contact no: +1 646-755-7667, +91 780-304-0404

0 notes

bhagyashribhole123 · 6 years ago

Text

Next Generation Sequencing Market 2019 Global Overview, Regional Analysis, Size, Share and Forecast to 2023

Market Research Future (MRFR) speculates that the global next generation sequencing market is presumed to demonstrate a healthy growth rate during the forecast period (2018-2023) owing to the technological advancements. Next-generation sequencing (NGS), also termed as high throughput sequencing technology or massively parallel sequencing, has revolutionized the biological sciences. The NGS technology has transformed genomic research to an advanced level and allows to sequence a complete human genome in a small duration. The genetic material is pulled out in this process, fragmented, and associated with primers and adapters for amplification.

Increasing awareness, employment of various growth strategies and ongoing technical advancements are expected to provide the market with ample opportunity for growth. However, the high initial cost of implementing technologies, and the requirement for storage of large volumes of data as well as a lack of skilled workforce to run the technology are challenges to the growth of the market.

Get Free Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6354

Moreover, NGS is used to execute applications like oncology studies, biomarker discovery, agricultural & animal research, personalized medicine, and others. It has extensively replaced conventional tools of genomics. The demand has further increased across the world due to the increasing R&D investments by several market giants.

On the contrary, lack of skilled workforce in order to store and manage the huge amount of data appropriately, proper healthcare infrastructure, and the high cost associated with the technology are some of the top barriers predicted to vitiate the market growth in the coming years. Moreover, the complications associated with data storage is likely to dampen the market growth to a certain extent.

Industry Updates

February 18, 2019: QIAGEN N.V. has recently announced an agreement with the Ares Genetics in order to develop innovative bioinformatics and assay solutions to augment research targeting the global health challenges posed by antibiotic-resistant bacteria.

Segments for Global Next Generation Sequencing Market

The Global Next Generation Sequencing Market has been segmented on the basis of service and product, technology, end-user, and application.

By mode of technology, the global next-generation sequencing market has been segmented into whole exome sequencing, whole genome sequencing, methyl sequencing, CHIP sequencing, RNA sequencing, targeted resequencing, and de novo sequencing.

By mode of service and product, the global next-generation sequencing market has been segmented into consumables, sample preparation, sequencing services, and platforms and services for platforms. Among these, the consumables segment is likely to occupy the largest market share owing to the increasing sequencing procedures, advancements in the sequencing technologies, rising adoption and installation of NGS platforms, and launch of easy to use consumables.

By mode of application, the global next-generation sequencing market has been segmented into the genetic screening, drug discovery, agriculture and animal research, diagnostics, and others. Among these, the diagnostic segment is predicted to experience the highest growth rate owing to the rising number of new cancer cases globally, growing focus of key market players, and favorable reimbursement policies for NGS-based tests.

By mode of end-users, the global next-generation sequencing market has been segmented into hospitals and clinics, academic institutes and research centers, pharmaceutical and biotechnology companies, and others.

Regional Analysis for Global Next Generation Sequencing Market

The Global Next Generation Sequencing Market is segmented into key regions which include the Americas, Asia Pacific, Europe, and the Middle East & Africa. North America in the Americas region is slated to lead the market with the largest share due to the high competition between market players in the region as well as the rising demand for next-gen sequencing in the healthcare sector of developed economies such as the US and Canada. Moreover, the presence of a significant healthcare sector in the region combined with growing investments in healthcare toward the development of therapies for chronic diseases will push growth during the forecast period.

The European region has the second largest market due to the significant R&D activities that take place in the region with regards to various fields including healthcare. The presence of pioneering next-gen sequencing technology market players are expected to make an impact on the market. However, growth here is restrained due to regulations and fragmentation of the market across Europe.

Get Complete Access of Report @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

#Next Generation Sequencing Market Next Generation Sequencing Market Report Next Generation Sequencing Market Research Next Generation Sequen

0 notes

marketreasearch · 7 years ago

Text

Global Next Generation Sequencing (NGS) Market Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2024

Global Next Generation Sequencing (NGS) Market,By Product (Instruments (Hiseq series, Miseq series, ION Torrent, SOLiD, Pacbio Rs II and Sequel system), Consumables (Sample preparation consumables, Other), Services (Sequencing services, Data management services), by Application (Diagnostics, Drug Discovery , Biomarker Discovery , Precision Medicine , Agriculture & Animal Research), by End-user (Hospitals & Clinics, Research Centers and Academic & Government Institutes, and Pharmaceutical & Biotechnology Companies), by Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Global Next-Generation Sequencing (NGS) Market accounted to USD 13.51 billion by 2022 growing at a CAGR of 22.7% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Ask for Free Sample Report @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-next-generation-sequencing-ngs-market

Global Next Generation Sequencing (NGS) Market Definition:

Next generation sequencing is also termed as high-throughput sequencing. It is a DNA sequencing technology in which millions and billions DNA strands are sequenced. It has revolutionized genomic research, as it minimizes the requirement for fragment-cloning methods used in Sanger sequencing of genomes.

Global Next Generation Sequencing (NGS) Market Competitive Analysis:

The Global Next-Generation Sequencing (NGS) Market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Global Next-Generation Sequencing (NGS) Market for global, Europe, North America, Asia Pacific and South America.

Questions? We’ll Put You On The Right Path Request Analyst Call @ http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-next-generation-sequencing-ngs-market

Global Next Generation Sequencing (NGS) Market Segmentation:

Global Next-Generation Sequencing (NGS) Market is segmented in Product and Services, which is segmented in Consumables, which is further bifurcated in Sample Preparation, which is again further classified in DNA Fragmentation, End Repair, A-Tailing, and Size Selection, Library Preparation & Target Enrichment, Quality Control and other consumables, Platforms, which is classified in HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II and Sequel System and other sequencing platforms, Sequencing Services, which is classified in RNA Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing, Chip Sequencing, De Novo Sequencing, Methyl Sequencing, Amplicon sequencing, Epigenomics, Digital Karyotyping and Metagenomics, Data Managemnet Services, which is further bifurcated in NGS Data Analysis Services, NGS Data Analysis Software & Workbenches, NGS Storage, Management and Cloud Computing Solutions.

By Technology the NGS market is segmented in Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing.

By Application the market is classified in Diagnostics, Drug Discovery, Biomarker Discovery, Precision Medicine, Agriculture and Animal Research, Reproductive Health, Personalized Medicine, Oncology, Clinical Investigation, Forensics,. HLA typing/Immune System Monitoring, Metagenomics, Epidemiology.

By End Users the market is spread in Hospitals & Healthcare institutions, Biotech & Pharma firms, Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Clinical Research.

By Geography the market covers the 5 major regions such as North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The major countries of the market are U.S., Canada, Mexico, Germany,France, Italy, Spain, India, Japan, China, Australia, South Korea, Taiwan, Brazil, Turkey, Suadi Arabia and South Africa among others. North America is dominating the market followed by the Europe.

Request for Detail TOC @ http://databridgemarketresearch.com/toc/?dbmr=global-next-generation-sequencing-ngs-market

Major Market Drivers and Restraints:

· Advanced technology in NGS platforms and increased applications of NGS.

· Increased in adoption of NGS among research laboratories and academic institutes.

· Efficient speed, cost, and accuracy of the technology.

· Drug discovery applications in NGS technology are some of the factors which drives the market.

· R&D investments are another factor to grow the market.

· Lack of skilled technicians.

· Accuracy and uniformity concerns in diagnostics testing limits the growth of market.

· Interpretation of complex data and issues regarding storage of sequencing data hinders the market.

· Legal and ethical issues are the challenge in the growing market.

· Emerging markets are proving the new opportunities in the growth of the market.

· Application of NGS in precision medicines & Biomarker discovery.

(NGS) Major Market Competitors:

Some of the major players operating in cancer supportive care products market are Illumina, Inc., Thermo Fisher Scientific Inc., Pacific Biosciences of California, Inc., QIAGEN, BGI, Oxford Nanopore Technologies, PerkinElmer, Inc., GATC Biotech AG, Agilent Technologies, F. Hoffmann-La Roche Ltd, Macrogen, Inc., Eurofins Scientific, Biomatters Limited, Genomatix GmbH, PierianDx, Myriad Genetics, Inc., Partek Incorporated, DNASTAR, Inc., New England Biolabs among others.

Read more about the Global Next Generation Sequencing Market @ http://databridgemarketresearch.com/reports/global-next-generation-sequencing-ngs-market/

Related Report:

Process oils Market – Industry Trends and Forecast to 2024

Global Process Oils Market By Type (Naphthenic, Non-Carcinogenic, Aromatic, Paraffinic); By Containing Materials (Peptizers, Fatty Acid Derivatives, Petroleum Oils, Polymers, Waxes) By Application (Tire & Rubber, Polymer, Textile, Polymer, Others), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024

Report Access@ http://databridgemarketresearch.com/reports/process-oils-market/

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Vishal Dixit

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

Investor: [email protected]

Visit Blog: http://databridgemarketresearch.com/blog/

https://www.linkedin.com/company/data-bridge-market-research

#Next Generation Sequencing

0 notes

bhagyashribhole123 · 6 years ago

Text

Next Generation Sequencing Market Opportunities, Drivers, Manufacturers, Analysis and Forecasts Till 2023

Market Research Future (MRFR) speculates that the Global Next Generation Sequencing Market is presumed to demonstrate a healthy growth rate during the forecast period (2018-2023) owing to the technological advancements.

Key Players

Oxford Nanopore Technologies, Ltd., BGI, Pacific Biosciences of California, Inc., PerkinElmer, QIAGEN N. V., Eurofins Scientific, Agilent Technologies, Macrogen Inc, Illumina, Inc., and Thermo Fisher Scientific, Inc. are among the notable market players that have been included in MRFR’s competition tracking of the global next generation sequencing market.

Get Free Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6354

Market Highlights

Next-generation sequencing (NGS), also termed as high throughput sequencing technology or massively parallel sequencing, has revolutionized the biological sciences. The NGS technology has transformed genomic research to an advanced level and allows to sequence a complete human genome in a small duration. The genetic material is pulled out in this process, fragmented, and associated with primers and adapters for amplification.

Industry Updates

Regional Analysis

Segments

The Global Next Generation Sequencing Market has been segmented on the basis of service and product, technology, end-user, and application.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354

About Market Research Future:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]

0 notes